Measurement of Gastric Emptying During and After COLOKIT® Intake
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subject who signed an informed consent to participate in the trial.
Subject affiliated with Social Security
Men and women aged 18 to 75 years.
Subject with an indication of scheduled outpatient colonoscopy.
colonoscopy performed within six hours after the second sequence COLOKIT®.
Subject able to swallow tablets.
Women pregnant or likely to be (without contraception) or nursing.
Subject having any of the following diseases or conditions:
allergy or hypersensitivity to the product tested or any of its excipients,
nausea, vomiting or abdominal pain,
clinically significant renal failure,
primary hyperparathyroidism associated with hypercalcemia,
congestive heart failure,
a known or suspected bowel obstruction,
megacolon (congenital or acquired)
an inflammatory disease or suspected inflammatory bowel disease,
known digestive motor disorders (gastroparesis, scleroderma, mega-esophagus),
diabetes mellitus (insulin or non insulin-dependent)
a history of gastric surgery (partial or total)
a contraindication to the anesthesia required for the completion of the colonoscopy,
Any clinical condition which, in the opinion of the investigator, would not allow the subject to perform the test in good conditions.